- Home
- OMAB vs TERN Comparison
OMAB vs TERN Comparison
Compare OMAB & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMAB | TERN |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | Mexico | United States |
| Employees | 1326 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OMAB | TERN |
|---|---|---|
| Price | $111.14 | $52.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $120.00 | $46.49 |
| AVG Volume (30 Days) | 87.2K | ★ 7.5M |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.36 | N/A |
| Revenue Next Year | $13.05 | N/A |
| P/E Ratio | $21.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $84.74 | $2.82 |
| 52 Week High | $134.99 | $53.19 |
Technical Indicators
Market Signals| Indicator | OMAB | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 74.74 |
| Support Level | $110.22 | $52.42 |
| Resistance Level | $114.48 | $53.19 |
| Average True Range (ATR) | 3.14 | 0.10 |
| MACD | -0.07 | -0.38 |
| Stochastic Oscillator | 4.31 | 98.78 |
Price Performance
Historical ComparisonAbout OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.